articleThe LancetAug 1, 2012Closed access

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial

Middlemore Hospital · Counties Manukau District Health Board · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

586
total citations
FWCI
43.57
Percentile
100%
References
38
Citations per year

Authors

12

Topics & keywords

Keywords
  • Medicine
  • Azithromycin
  • Bronchiectasis
  • Placebo
  • Exacerbation
  • Internal medicine
  • Randomized controlled trial
  • Rate ratio
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.